1887

Abstract

The major neutralization antigen VP7 of rhesus rotavirus (RRV) was expressed in a baculovirus recombinant system. The expressed VP7 showed the same molecular mass as native VP7, and was recognized by hyperimmune sera as well as neutralizing and non-neutralizing monoclonal antibodies (MAbs) raised against RRV. Intraperitoneal administration of the expressed VP7 in mice elicited the production of serum antibodies which were able to immunoprecipitate VP7 from RRV-infected cell lysates and to neutralize the virus . Sera from immunized mice competed for binding to RRV in an ELISA with both neutralizing and non-neutralizing MAbs specific for VP7. Using a passive protection model of rotavirus disease, vaccination of mice with the recombinant VP7 induced partial protection from infection. These results suggest that the baculovirus-expressed VP7 may be useful in priming a protective immune response to rotavirus infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-8-1981
1995-08-01
2022-05-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/8/JV0760081981.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-8-1981&mimeType=html&fmt=ahah

References

  1. Anderson E. L., Belshe K. B., Bartram J., Crookshanks-Newman F., Chanock R. M., Kapikian A. Z. 1986; Evaluation of rhesus rotavirus vaccine (MMU18006) in infants and young children. Journal of Infectious Diseases 153:823–831
    [Google Scholar]
  2. Andrew M. E., Boyle D. B., Coupar B. E., Whitfeld P. L., Both G. W., Bellamy A. R. 1987; Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies. Journal of Virology 61:1054–1060
    [Google Scholar]
  3. Andrew M. E., Boyle D. B., Whitfeld P. L., Lockett L. J., Anthony I. D., Bellamy A. R., Both G. W. 1990; The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression. Journal of Virology 64:4776–4783
    [Google Scholar]
  4. Andrew M. E., Boyle D. B., Compar B. E., Reddy A. B. O., Bellamy A. R., Both G. W. 1992; Vaccinia rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine 10:185–191
    [Google Scholar]
  5. Arias C. F., Ballado T., Plebaski M. 1986; Synthesis of the outer-capsid glycoprotein of the simian rotavirus SA11 in Escherichia coli . Gene 47:211–219
    [Google Scholar]
  6. Both G. W., Lockett L. J., Janardhana V., Edwards S. J., Bellamy A. R., Graham F. L., Prevee L., Andrew M. E. 1993; Protective immunity to rotavirus induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7. Virology 163:940–950
    [Google Scholar]
  7. Clark H. F., Furukawa T., Bell L. M., Offit P. A., Perrella P. A., Plotkin S. A. 1986; Immune response of infants and children to low passage bovine rotavirus strain (strain WC3). American Journal of Disease in Children 140:350–356
    [Google Scholar]
  8. Coulson B. 1987; Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism. Virology 159:209–216
    [Google Scholar]
  9. Crawford S. E., Labbé M., Cohen J., Burroughs M. H., Zhou Y. J., Estes M. K. 1994; Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. Journal of Virology 68:5945–5952
    [Google Scholar]
  10. De Mol P., Zissis G., Butzler J. P., Mutwewingbabo A., Andre F. E. 1986; Failure of live, attenuated oral rotavirus vaccine. Lancet ii:108
    [Google Scholar]
  11. De Zoysa I., Feachem R. G. 1985; Interventions for the control of diarrhoeal disease among young children: rotavirus and cholera immunization. Bulletin of the World Health Organization 63:569–583
    [Google Scholar]
  12. Dormitzer P. R., Dora Y. H., Mackow E. R., Mocarski E. S., Greenberg H. B. 1992; Neutralizing epitopes on herpes simplex virus-1 expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology 187:18–32
    [Google Scholar]
  13. Dormitzer P. R., Both G. W., Greenberg H. B. 1994; Presentation of neutralizing epitopes by engineered rotavirus VP7s expressed by recombinant vaccinia viruses. Virology 204:391–402
    [Google Scholar]
  14. Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Norpthop J. P., Ringold J. M., Danielson M. 1987; Lipofection: A highly efficient lipid mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences, USA 84:7413–7417
    [Google Scholar]
  15. Fiore L., Greenberg H. B., Mackow E. R. 1991; The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181:553–563
    [Google Scholar]
  16. Flores J., Perez-Schael I., Blanco M., White L., Garcia D., Vilar M., Cunto W., Gonzales R., Urbina C., Boher J., Mendez J., Kapikian A. Z. 1988; Reactogenicity and antigenicity of two human rhesus-rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan children. Journal of Clinical Microbiology 27:512–518
    [Google Scholar]
  17. Francavilla M., Miranda P., Di Matteo A., Sarasini A., Gerna G., Milanesi G. 1987; Expression of bovine rotavirus neutralization antigen in Escherichia coli . Journal of General Virology 68:2975–2980
    [Google Scholar]
  18. Green K. Y., Taniguchi K., Mackow E. R., Kapikian A. Z. 1990; Homotypic epitope-specific antibody responses in adult and infants rotavirus vaccines: implication for vaccine development. Journal of Infectious Diseases 161:667–679
    [Google Scholar]
  19. Greenberg H. B., McAuliffe V., Valdesuso J., Wyatt R. G., Flores J., Kalica A., Hoshino Y., Sing N. 1983a; Serological analysis of the subgroup protein of rotavirus using monoclonal antibodies. Infection and Immunity 39:91–99
    [Google Scholar]
  20. Greenberg H. B., Valdesuso J., Van Wyke K., Midthun K., Walsh M., McAuliffe U., Wyatt R. G., Kalica A. R., Flores J., Hoshino Y. 1983b; Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. Journal of Virology 47:267–275
    [Google Scholar]
  21. Hanlon P., Hanlon L., Marsh V., Byass P., Shenton F., Hassan-King M., Sillah H., M’Boge B. H., Greenwood B. M. 1987; Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet i:1342–1345
    [Google Scholar]
  22. Harlow E., Lane D. 1988 Antibodies: A Laboratory Manual Cold Spring Harbor, New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  23. Hoshino Y., Saif L. J., Sereno M. M., Chanock R. M., Kapikian A. Z. 1988; Infection immunity of piglets to either VP3 and VP7 outer capsid proteins confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. Journal of Virology 62:744–748
    [Google Scholar]
  24. Kalika A. R., Flores J., Greenberg H. B. 1983; Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology 125:194–205
    [Google Scholar]
  25. Kapikian A. Z., Chanock R. M. 1990; Rotaviruses. In Virology 2nd edn, pp 1353–1404 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  26. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
    [Google Scholar]
  27. McCrae M. A., Corquodale J. G. 1987; Expression of a major bovine rotavirus neutralization antigen (VP7c) in Escherichia coli . Gene 55:9–18
    [Google Scholar]
  28. McGonigal T. P., Turan M. C., Komar-Hartett K., Kister S. E., Smith R. E. 1992; Expression of the gene coding for the major outer capsid protein SA11 rotavirus in a baculovirus system. Virus Research 23:135–150
    [Google Scholar]
  29. Mackow E. R., Barnett J. W., Chan H., Greenberg H. B. 1989; The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. Journal of Virology 63:1661–1668
    [Google Scholar]
  30. Mackow E. R., Vo P. T., Broomer R., Bass D. M., Greenberg H. B. 1990; Immunization with baculoviros-expressed VP4 protein passively protects against simian and murine rotavirus challenge. Journal of Virology 64:1698–1703
    [Google Scholar]
  31. Matsuura Y., Possee R. D., Overton A., Bishop D. H. L. 1987; Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. Journal of General Virology 68:1233–1250
    [Google Scholar]
  32. Midthun K., Greenberg H. B., Hoshino Y., Kapikian A. Z., Wyatt R. G., Chanock R. M. 1985; Reassortant rotaviruses as potential live rotavirus vaccine candidates. Journal of Virology 53:949–954
    [Google Scholar]
  33. Offit P. A., Blavat G. 1986; Identification of the two rotavirus genes determining neutralization specificities. Journal of Virology 57:376–378
    [Google Scholar]
  34. Offit P. A., Clark H. F., Blavat G., Greenberg H. B. 1986a; Reassortant rotaviruses containing structural proteins VP3 and VP7 from different parents induce antibodies protective against each parental serotype. Journal of Virology 60:491–496
    [Google Scholar]
  35. Offit P. A., Shaw R. D., Greenberg H. B. 1986b; Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. Journal of Virology 58:700–703
    [Google Scholar]
  36. Redmont M. J., Ijaz M. K., Sabara M. D., Dent D., Gibbons E., Babiuk L. A. 1993; Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine 11:273–281
    [Google Scholar]
  37. Ruggeri F. M., Greenberg H. B. 1991; Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. Journal of Virology 65:2211–2219
    [Google Scholar]
  38. Sanger R., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74:5463–5467
    [Google Scholar]
  39. Shaw R. D., Stoner M. A., Estes K., Greenberg H. B. 1985; Specific enzyme linked immunoassay for rotavirus serotypes 1 and 3. Journal of Clinical Microbiology 22:286–291
    [Google Scholar]
  40. Shaw R. D., Vo P. T., Offit P. A., Coulson B. S., Greenberg H. B. 1986; Antigenic mapping of the surface proteins of rhesus rotavirus. Virology 155:434–451
    [Google Scholar]
  41. Vesikari T. 1993; Clinical trials of live oral rotavirus vaccine: the Finnish experience. Vaccine 11:255–261
    [Google Scholar]
  42. Vesikari T., Isolauri E., Delem A., D’Honot E., André F. E., Beards G. M., Flewett T. H. 1985; Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. Journal of Pediatrics 107:189–194
    [Google Scholar]
  43. Ward R. L., Knowlton D. R., Greenberg H. B., Schiff G. M., Bernstein D. I. 1986; Serum neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. Journal of Virology 64:2687–2691
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-8-1981
Loading
/content/journal/jgv/10.1099/0022-1317-76-8-1981
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error